The Member States have criticized and in fact rejected a proposal by the European Commission on a new type of regulation on genetically modified organisms (GMOs). According to EUobserver both pro-GMO and anti-GMO Member States have objected the newly proposed regime. The Commission proposal provides that the general approval of the GMO will still be made on EU level under current rules, but once GMOs are approved, Member States will be able to decide whether to allow the introduction of the GMOs on their territory or not.
This reaction is not surprising, but the current discord on GMOs must be managed somehow. So the Commission proposal at least provides a starting point for negotiations. Member States should also keep in mind that they need the approval of the European Parliament, where reaching a consensus will also be difficult.
Posted in Agriculture and Fisheries, Consumers' Protection, Environment, Healthcare, Internal Market
Tagged approval, European Commission, European Parliament, GMO, Member States, regime, regulation
The Commission has finally made a proposal on a new regime for the approval of genetically modified organisms (GMO). The Commission proposes to confer to Member States the freedom to allow, restrict or ban the cultivation of Genetically Modified Organisms (GMOs) on part or all of their territory. The general approval of the GMO will still be made on EU level under current rules, but once GMOs are approved, Member States will be able to decide whether to allow the introduction of the GMOs on their territory or not.
After almost 10 years after the adoption of Directive 2001/18/EC the Commission has made a positive step forward for the resolution of this very serious problem. The stalled comitology procedure for the approval of GMOs has been a rare example of systemic institutional failure of the EU (see also the excellent book by Mark Pollack and Gregory Shaffer: When cooperation fails: the international law and politics of genetically modified foods). Now, hopefully, this will change.
Given the fact that both the biotech industry and the environmentalists criticize the proposal, there may be a grain of salt to it.